NovogeneAIT Genomics, headquartered in Singapore, is a premier provider of multi-omics services and solutions. Established in 2016 through a strategic joint venture between Novogene and AITbiotech, we have grown to be one of the largest NGS service providers in Southeast Asia.
Our unwavering commitment to delivering high-quality, efficient, and cost-effective omics solutions has propelled us to the forefront of genomic research. NovogeneAIT Genomics offers an extensive range of multi-omics services, including genomics, transcriptomics, single-cell/spatial transcriptomics, metagenomics, and proteomics. Operating from our cutting-edge sequencing center in Singapore, we are dedicated to advancing scientific research by providing superior data quality.
For more information, visit www.novogene.com/amea-en/
-
Industry
-
Biotechnology Research
-
Company size
-
1,001-5,000 employees
-
Headquarters
-
Singapore
-
Type
-
Public Company
-
Founded
-
2016
-
Specialties
-
Next Generation Sequencing, Genome Sequencing, Precision Medicine, Bioinformatics, genomics, multi omics, spatial transcriptomcs, long-read sequencing, metagenomics, single cell, population genomics, proteomics, epigenomics, transcriptomics, genomics, metabolomics, Revio, Nanopore, Olink, stereo-seq, and Visium HD